0.7826
price down icon3.31%   -0.0268
after-market After Hours: .79 0.0074 +0.95%
loading

Tempest Therapeutics Inc Stock (TPST) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Interest Income/Expense
2.39%
0.368
0.377 0.373 0.355 0.344
Operating Income/Loss
6.12%
-7.974
-7.514 -6.592 -7.47 -7.581
Nonoperating Income/Loss
169.23%
0.07
0.026 -0.194 -0.111 -0.055
Income/Loss From Continuing Operations Before Tax
5.56%
-7.904
-7.488 -6.786 -7.581 -7.636
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
5.56%
-7.904
-7.488 -6.786 -7.581 -7.636
Net Income/Loss
5.56%
-7.904
-7.488 -6.786 -7.581 -7.636
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1,538%
22.23
1.3572 14.12 14.10 13.76
Diluted Average Shares
1,538%
22.23
1.3572 14.12 14.10 13.76
Basic Earnings Per Share
5.88%
-0.36
-0.34 -0.48 -0.54 -0.55
Diluted Earnings Per Share
5.88%
-0.36
-0.34 -0.48 -0.54 -0.55
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$76.29
price down icon 6.45%
$22.96
price up icon 1.23%
$33.86
price up icon 0.65%
$19.13
price down icon 7.54%
biotechnology ONC
$245.53
price down icon 9.67%
$111.56
price down icon 1.20%
Cap:     |  Volume (24h):